SGHT (Sight Sciences, Inc) Prakiraan pendapatan perusahaan

Tandha merek Sight Sciences, Inc (SGHT)

The GURU.Markets terminal features a chart of the projected sales volume, where the latest value is recorded as 0.09. This trend for Sight Sciences, Inc. (SGHT) is driven by the popularity of the OMNI system and the implementation of TearCare. High margins are based on the uniqueness of its glaucoma tools. The stability of operating metrics relies on the expansion of insurance coverage and steady demand for ophthalmological interventions.

SGHT - Volume dodolan sing dikarepake perusahaan Sight Sciences Inc ing rentang 04.07.2022 - 17.11.2026

Rincian analitis lan laporan data perusahaan Sight Sciences, Inc (SGHT)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:sightsciences.com
Produk merek Sight Sciences Inc.

Amid intense competition with medtech giants for the loyalty of ophthalmologists, sales volume expectations for Sight Sciences, Inc. (SGHT) reflect market confidence in the resilience of the company's commercial model. This indicator synthesizes the projected revenue stream, assessing the business's ability to generate income under stress scenarios, which allows investors to identify risks of a sharp decline in demand for innovative glaucoma treatment devices.

Analisis perusahaan pesaing

Prakiraan pendapatan perusahaan Boston Scientific Corp (BSX)|EW - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan RMD (resmed.com)|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer Biomet Holdings, Inc. - Prakiraan volume dodolan|COO (The Cooper Companies) - Prakiraan pendapatan perusahaan|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|TMDX (TransMedics Corp) - Prakiraan volume dodolan|ATEC Spine (ATEC) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan AORT|Volume dodolan mangsa ngarep perusahaan Enovis Corporation ENOV|Prakiraan volume dodolan IART (integralife.com)|Prakiraan volume dodolan Establishment Labs Corp ESTA|BBNX - Prakiraan pendapatan perusahaan|IRMD: Prakiraan pendapatan perusahaan|EMBC (Embecta Corp.) - Volume dodolan mangsa ngarep perusahaan|Tandem Diabetes Care - Pendapatan mangsa ngarep perusahaan|AXGN (Axogen Surgical) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan SI-BONE Inc SIBN|Prakiraan pendapatan perusahaan Orthofix Medical (OFIX)|Prakiraan volume dodolan Bioventus Corp (BVS)|OrthoPediatrics Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Treace Medical Concepts TMCI|Blade Air Mobility - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Carlsmed, Inc. CARL|RxSight (RXST) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan CLPT (ClearPoint)|Prakiraan pendapatan perusahaan stereotaxis.com|Volume dodolan mangsa ngarep perusahaan Neuronetics, Inc. (STIM)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD, Inc. NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings, Inc. - Prakiraan volume pendapatan perusahaan|NeuroOne Corp (NMTC) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Modular Med|Prakiraan pendapatan perusahaan myomo.com|Prakiraan pendapatan perusahaan COCH (Envoy Medical, Inc.)|Volume dodolan mangsa ngarep perusahaan VVOS (Vivos Therapeutics)|Prakiraan pendapatan perusahaan NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Volume dodolan mangsa ngarep perusahaan|Tenon Medical Inc. (TNON) - Volume dodolan sing dikarepake perusahaan|LFWD - Prakiraan pendapatan perusahaan|AMIX (Autonomix Medical) - Prakiraan pendapatan perusahaan|IVF: Prakiraan volume dodolan|BBLG (Bone Biologics) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Axonics Inc.|Volume dodolan sing dikarepake perusahaan Biolase, Inc. BIOL|Prakiraan pendapatan perusahaan Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan invobioscience.com INVO